Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-07-016735
Filing Date
2007-08-14
Accepted
2007-08-14 18:00:45
Documents
1
Period of Report
2007-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 36965
  Complete submission text file 0001179110-07-016735.txt   38646
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Issuer) CIK: 0001008848 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACORDA THERAPEUTICS, INC. 15 SKYLINE DRIVE HAWTHORNE NY 10532
Business Address 914-347-4300
COHEN RON (Reporting) CIK: 0001272354 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50513 | Film No.: 071057389